 primari cn lymphoma osmot blood-brain barrier disrupt prolong surviv preserv cognit function combin chemotherapi radiotherapi modest efficaci treatment primari cn lymphoma median surviv patient radiotherapi month surviv thirti consecut non-acquir immun defici syndrom patient primari cn lymphoma barrier-depend chemotherapi intraarteri mannitol blood-brain barrier bbb follow-up extens neuropsycholog test patient thirteen patient cranial radiat month referr group seventeen patient initi bbb disrupt chemotherapi subsequ radiat tumor progress recurr group differ median surviv diagnosi month group month group signific group surviv compar median surviv histor seri patient radiotherapi chemotherapi group patient surviv advanc surviv cn lymphoma preserv cognit function complet respond year patient toxic manag intens therapeut regimen seri plateau surviv curv major portion patient neuropsycholog sequela cranial radiat